Comparing Long-Term Infliximab Persistence Following a Switch to a Biosimilar in Patients With Inflammatory Bowel Disease: No Cause for Concern
PMID: 40016953
Source: J Gastroenterol Hepatol
DOI:
10.1111/jgh.16916
Publication date:
2025-02-28
Year:
2025
Abstract
NULL